These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 20841468)
1. Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis. Cheng X; Xia W; Yang JY; Hsu JL; Lang JY; Chou CK; Du Y; Sun HL; Wyszomierski SL; Mills GB; Muller WJ; Yu D; Hung MC Cancer Res; 2010 Oct; 70(19):7684-9. PubMed ID: 20841468 [TBL] [Abstract][Full Text] [Related]
2. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
3. Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models. Blanco-Aparicio C; Cañamero M; Cecilia Y; Pequeño B; Renner O; Ferrer I; Carnero A PLoS One; 2010 Feb; 5(2):e9305. PubMed ID: 20174572 [TBL] [Abstract][Full Text] [Related]
4. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953 [TBL] [Abstract][Full Text] [Related]
5. Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis. Cheng X; Xia W; Yang JY; Hsu JL; Chou CK; Sun HL; Wyszomierski SL; Mills GB; Muller WJ; Yu D; Hung MC Biochem Biophys Res Commun; 2010 Dec; 403(1):103-7. PubMed ID: 21040707 [TBL] [Abstract][Full Text] [Related]
6. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK. Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis. Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670 [TBL] [Abstract][Full Text] [Related]
8. The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis. Volk EL; Fan L; Schuster K; Rehg JE; Harris LC Mol Cancer Res; 2009 Jun; 7(6):863-9. PubMed ID: 19491200 [TBL] [Abstract][Full Text] [Related]
9. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Lundgren K; Montes de Oca Luna R; McNeill YB; Emerick EP; Spencer B; Barfield CR; Lozano G; Rosenberg MP; Finlay CA Genes Dev; 1997 Mar; 11(6):714-25. PubMed ID: 9087426 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342 [TBL] [Abstract][Full Text] [Related]
11. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967 [TBL] [Abstract][Full Text] [Related]
12. Preconditioning-Activated AKT Controls Neuronal Tolerance to Ischemia through the MDM2-p53 Pathway. Barrio E; Vecino R; Sánchez-Morán I; Rodríguez C; Suárez-Pindado A; Bolaños JP; Almeida A; Delgado-Esteban M Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298892 [TBL] [Abstract][Full Text] [Related]
13. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133 [TBL] [Abstract][Full Text] [Related]
14. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Maroulakou IG; Oemler W; Naber SP; Tsichlis PN Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696 [TBL] [Abstract][Full Text] [Related]
16. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis. Liu K; Xue B; Bai G; Zhang W Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832 [TBL] [Abstract][Full Text] [Related]
17. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis. Liu S; Tackmann NR; Yang J; Zhang Y Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574 [TBL] [Abstract][Full Text] [Related]
18. 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling. Danes CG; Wyszomierski SL; Lu J; Neal CL; Yang W; Yu D Cancer Res; 2008 Mar; 68(6):1760-7. PubMed ID: 18339856 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of MDM2, cyclin D1, and p27Kip1 in carcinogen-induced rat mammary tumors. Murray SA; Yang S; Demicco E; Ying H; Sherr DH; Hafer LJ; Rogers AE; Sonenshein GE; Xiao ZX J Cell Biochem; 2005 Aug; 95(5):875-84. PubMed ID: 15844214 [TBL] [Abstract][Full Text] [Related]
20. Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells. Singh S; Ramamoorthy M; Vaughan C; Yeudall WA; Deb S; Palit Deb S Cell Death Differ; 2013 Apr; 20(4):558-66. PubMed ID: 23238568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]